Last reviewed · How we verify
NCT03889002: NOHID
North Health in Intellectual Disability
trial in Intellectual Disabilities (F70-F79) in 214 participants. Completed in 9 December 2019.
9 December 2019
Quick facts
| Lead sponsor | University Hospital of North Norway |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 214 |
| Start date | 1 October 2017 |
| Primary completion | 9 December 2019 |
| Estimated completion | 9 December 2019 |
| Sites | 1 location across Norway |
Conditions studied
- Intellectual Disabilities (F70-F79) — all drugs for Intellectual Disabilities (F70-F79) →
Sponsor
University Hospital of North Norway
Who can join
16 and older, any sex, with Intellectual Disabilities (F70-F79). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intellectual disability (ID) is a diagnosis characterized by significant limitations both in intellectual functioning and in adaptive behavior as expressed in conceptual, social and practical adaptive skills. The disability originates before age 18 years. People with IDs will often require health- and social services throughout their lifetimes. Studies report worse health among people with IDs compared to the general population, in addition to more unmet healthcare needs and more difficulty accessing healthcare. There are also concerns about low levels of physical activity in this population. In general health surveys in Norway do not include people with intellectual disabilities, and studies of health indicators in this group are largely lacking. Further, the unique organization of services for this group in Norway calls for specific research efforts. This project will use multinational health indicators for youths and adults with IDs in a biopsychosocial context in attempt to identify unmet health care needs to improve services. In addition to a description of the health indicators, the objective of this project is delimited to assess the health determinant physical activity level in association with body mass index (BMI) and functioning.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Use of health and dental care services in adults with intellectual disability in relation to age and intellectual disability levels.
Olsen MI, Søndenaa E, Langballe EM, Halvorsen MB, et al · · 2023 · cited 4× · PMID 39815906 · DOI 10.3109/13668250.2022.2109823
Verify or expand the search:
- PubMed search for NCT03889002
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intellectual Disabilities (F70-F79)
Currently open trials in the same condition.
- NCT07101523 — Using Technologies to Promote HEalthy Lifestyles in Adolescents With Intellectual Disabilities · NA · recruiting
Other University Hospital of North Norway trials
Trials by the same sponsor.
- NCT07343895 — Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tromsø Study · NA · recruiting
- NCT07149246 — The Effect of a 6-month Dietitian-tailored Nutrition Intervention to Patients With Critical Illness (DETAIL) · NA · recruiting
- NCT07092904 — Myocardial Infarction Safe Emergency Medicine Accompanying Study: Providing Reperfusion Therapy Within the Recommended T · not yet recruiting
- NCT07530588 — Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis · NA · recruiting
- NCT06881758 — High Intensity Training for Patients with Anxiety · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03889002 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital of North Norway
- Last refreshed: 6 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03889002.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing